This inventor holds 6 USPTO granted patents. Top assignees: The Dupont Merck Pharmaceutical Company, E.i. Dupont De Nemours and Company. Active years: 1990-1995.
Company Filing History:

Years Active: 1990-1995
Title: Innovations of Chung-Ho Park
Introduction
Chung-Ho Park is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment and antibacterial activity. With a total of 6 patents to his name, Park's work exemplifies the intersection of chemistry and medicine.
Latest Patents
Among his latest patents, Park has developed processes for preparing bis-naphthalimides containing amino-acid derived compounds. This invention includes specific bis-naphthalimides, such as 2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione] and 2,2'-[1,2-ethanediylbis[imino(2-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione]. These compounds are designed for use in pharmaceutical compositions aimed at treating cancer in mammals. Additionally, he has created novel aminomethyloxooxazolidinyl arylbenzene derivatives, which exhibit useful antibacterial activity.
Career Highlights
Chung-Ho Park has worked with prominent companies in the pharmaceutical industry, including the DuPont Merck Pharmaceutical Company and E.I. du Pont de Nemours and Company. His experience in these organizations has allowed him to contribute to significant advancements in drug development and innovation.
Collaborations
Throughout his career, Park has collaborated with notable colleagues such as Walter A. Gregory and Randall K. Carlson. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his inventions.
Conclusion
Chung-Ho Park's innovative work in the pharmaceutical field has led to the development of important compounds with potential therapeutic applications. His contributions continue to influence the landscape of drug discovery and development.